Paid Clinical Trials in Lawrenceville, GA
As of August 2026, 59 paid clinical trials are recruiting in Lawrenceville, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lawrenceville offers studies at sites including Northside Hospital - Gwinnett for conditions such as Obesity, Overweight, IgA Nephropathy, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lawrenceville
Trials by drug in Lawrenceville
Filter results
Newly added in Lawrenceville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
58 clinical trials
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Top Research Study Locations in Lawrenceville
Researchers run research studies in Lawrenceville, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northside Hospital - Gwinnett | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 13 |
| Teak Research Consults | Obesity, Overweight, Diabetes Mellitus, Type 2 | 6 |
| Georgia Nephrology | End Stage Kidney Disease, IgA Nephropathy, Primary Membranous Nephropathy | 3 |
| Physicians Research Associates | Obesity, Obstructive Sleep Apnoea, Overweight | 3 |
| Balanced Life Health Care Solutions | Hypercholesterolemia, Type 2 Diabetes | 2 |
| Georgia Nephrology Research Inst | C3 Glomerulopathy, Glomerulonephritis, IGA, Immune-complex-membranoproliferative Glomerulonephritis | 2 |
| Parris and Associates Rheumatology | Lupus Nephritis, Systemic Lupus Erythematosus | 2 |
| Salveo Integrative Health - Lawrenceville | Schizophrenia, Autism-Related Irritability | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
| Balanced Life Health Care Solutions/SKYCRNG | Type 2 Diabetes, Coronavirus Disease (COVID-19) | 2 |
| Investigator | Focal Segmental Glomerulosclerosis, C3 (Complement Component 3) Glomerulopathy, IgA Nephropathy | 2 |
| Physicians Research Associates, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Alliance Spine and Pain Ctrs | Lumbar Spinal Stenosis | 1 |
| Ambros Clinical Trial Site | Complex Regional Pain Syndrome Type I | 1 |
| Clinical Research | Immunoglobulin A Nephropathy | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| GA Interventional Pain, LLC | Lumbar Spinal Stenosis | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Georgia Clinical Research | Cardiovascular Disease | 1 |
| Georgia Nephrology - Lawrenceville - Billing Office | Proteinuric Kidney Disease | 1 |
| Georgia Nephrology Research Institute | Lupus Nephritis | 1 |
| Gwinnett Med Ctr | Lumbar Spinal Stenosis | 1 |
| North Georgia Rheumatology Group PC | Psoriatic Arthritis | 1 |
Active & Upcoming Studies in Lawrenceville (2026)
Recruiting trials in Lawrenceville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · Phase 3 · Alliance for Clinical Trials in Oncology
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (12 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (4 active studies)
- AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
Cardiovascular (4 active studies)
- A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension · Phase 2 · Retension Pharmaceuticals. Inc.
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Mental health & behavior (2 active studies)
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) · Phase 3 · Bristol-Myers Squibb
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Common conditions studied in Lawrenceville
- Obesity (8 active studies)
- Overweight (8 active studies)
- IgA Nephropathy (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Chronic Weight Management (2 active studies)
Leading research sponsors in Lawrenceville
- Eli Lilly and Company
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- Novartis Pharmaceuticals
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Lawrenceville?
There are approximately 59 recruiting clinical trials in Lawrenceville, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lawrenceville pay participants?
Most recruiting trials in Lawrenceville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lawrenceville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lawrenceville?
The most common conditions under active study in Lawrenceville include Obesity (8), Overweight (8), IgA Nephropathy (3), Stage IV Lung Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lawrenceville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lawrenceville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lawrenceville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lawrenceville?
Recruiting research sites in Lawrenceville include Northside Hospital - Gwinnett, Teak Research Consults, Georgia Nephrology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lawrenceville right now?
The largest active categories in Lawrenceville are Cancer & tumors (12), Diabetes & metabolic (12), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.